Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2005, Volume 29, Issue 2

Extrusion-spheronization and pellet compression are effective means of developing first-order kinetic, controlled-release drug delivery systems of azithromycin (AZI). The authors prepared, evaluated, and optimized AZI formulations and assessed the stability of the selected formulation under accelerated storage conditions.

Related Content:

Drug DeliveryFormulationSolid/Semi-Solid DosageManufacturingDevelopmentDosage FormsPharmaceutical Technology-02-02-2005
Moderna and Generation Bio Announce Strategic Collaboration
Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development
BioNTech and OncoC4 to Co-Develop mAb for Solid Tumor Indications